The image provides information on Exalgo. There is a title that reads "Exalgo has a well-characterized safety profile." Below that there are three sub-headings and additional text. The subheadings are: "Adverse reactions for EXALGO are typical of other opioids." "Reduced potential for certain drug interaction" and "No dose dumping".
On the right section there is the Exalgo logo at the top of the page. There is additional information about the European formulation of Exalgo called Jurnista. There is also a map of Europe.
Description
Type
Category
-
Date
2010
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
